Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, β-Synuclein

Journal of Neuroimmunology

Volumn 208, Issue 1-2, 2009, Pages 19-29

  Kela Madar, Neta ^a   de Rosbo, Nicole Kerlero ^a   Ronen, Ayal ^a   Mor, Felix ^a   Ben Nun, Avraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Antigens peptides epitopes; Autoantibodies; Autoimmunity; Rodent; T cells

Indexed keywords

AMINO ACID; BETA SYNUCLEIN; BRAIN ANTIGEN; ENCEPHALITOGENIC PROTEIN; EPITOPE; MYELIN; MYELIN ENCEPHALITOGEN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; DEMYELINATION; DISEASE ASSOCIATION; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; BETA-SYNUCLEIN; CELL LINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MYELIN SHEATH; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS;

EID: 62549105276     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.12.009     Document Type: Article

References (52)

1. Ackerman A.L., and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5 (2004) 678-684
2. Bailey S.L., Carpentier P.A., McMahon E.J., Begolka W.S., and Miller S.D. Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26 (2006) 149-188
3. Ben-Nun A., and Lando Z. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J. Immunol. 130 (1983) 1205-1209
4. Ben-Nun A., Kerlero de Rosbo N., Kaushansky N., Eisenstein M., Cohen L., Kaye J.F., and Mendel I. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 36 (2006) 478-493
5. Bjartmar C., and Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 14 (2001) 271-278
6. Bjartmar C., and Trapp B.D. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox. Res. 5 (2003) 157-164
7. Bjartmar C., Kidd G., Mork S., Rudick R., and Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48 (2000) 893-901
8. Bjartmar C., Wujek J.R., and Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206 (2003) 165-171
9. Chang Y.C., and Gottlieb D.I. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 8 (1988) 2123-2130
10. Charcot J. Histologie de la sclerose en plaques. Gaz. Hôp., Paris 41 (1868) 554-555
11. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., Blumenschein W., Churakovsa T., Low J., Presta L., Hunter C.A., Kastelein R.A., and Cua D.J. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116 (2006) 1317-1326
12. Cochran E., Bacci B., Chen Y., Patton A., Gambetti P., and Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am. J. Pathol. 139 (1991) 485-489
13. Eikelenboom M.J., Petzold A., Lazeron R.H., Silber E., Sharief M., Thompson E.J., Barkhof F., Giovannoni G., Polman C.H., and Uitdehaag B.M. Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 60 (2003) 219-223
14. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 (1997) 393-399
15. Furlan R., Brambilla E., Sanvito F., Roccatagliata L., Olivieri S., Bergami A., Pluchino S., Uccelli A., Comi G., and Martino G. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain 126 (2003) 285-291
16. Gennarelli T.A. The spectrum of traumatic axonal injury. Neuropathol. Appl. Neurobiol. 22 (1996) 509-513
17. Ghiringhelli F., Larmonier N., Schmitt E., Parcellier A., Cathelin D., Garrido C., Chauffert B., Solary E., Bonnotte B., and Martin F. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 34 (2004) 336-344
18. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., and Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005) 328-334
19. Heath W.R., Kurts C., Miller J.F., and Carbone F.R. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187 (1998) 1549-1553
20. Hermitte L., Martin-Moutot N., Boucraut J., Barone R., Atlan-Gepner C., Seagar M., Pouget J., Kleisbauer J.P., Couraud F., and Vialettes B. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome. J. Clin. Immunol. 20 (2000) 287-293
21. Huizinga R., Heijmans N., Schubert P., Gschmeissner S., t Hart B.A., Herrmann H., and Amor S. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J. Neuropathol. Exp. Neurol. 66 (2007) 295-304
22. Jack C., Ruffini F., Bar-Or A., and Antel J.P. Microglia and multiple sclerosis. J. Neurosci. Res. 81 (2005) 363-373
23. Jansson L., Diener P., Engstrom A., Olsson T., and Holmdahl R. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice. Eur. J. Immunol. 25 (1995) 2195-2200
24. Karman J., Ling C., Sandor M., and Fabry Z. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173 (2004) 2353-2361
25. Kaushansky N., Zhong M.C., Kerlero de Rosbo N., Hoeftberger R., Lassmann H., and Ben-Nun A. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 177 (2006) 7364-7376
26. Kerlero de Rosbo N., and Ben-Nun A. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. J. Autoimmun. 11 (1998) 287-299
27. Kerlero de Rosbo N., Kaye J.F., Eisenstein M., Mendel I., Hoeftberger R., Lassmann H., Milo R., and Ben-Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173 (2004) 1426-1435
28. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 566-573
29. Kuchroo V.K., Sobel R.A., Laning J.C., Martin C.A., Greenfield E., Dorf M.E., and Lees M.B. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 148 (1992) 3776-3782
30. Kuffova L., Netukova M., Duncan L., Porter A., Stockinger B., and Forrester J.V. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice. J. Immunol. 180 (2008) 1353-1361
31. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., and Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
32. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130 (1988) 443-454
33. Liu Y., Teige I., Birnir B., and Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12 (2006) 518-525
34. Matthews P.M., De Stefano N., Narayanan S., Francis G.S., Wolinsky J.S., Antel J.P., and Arnold D.L. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin. Neurol. 18 (1998) 327-336
35. Mathey E.K., Derfuss T., Storch M.K., Williams K.R., Hales K., Woolley D.R., Al-Hayani A., Davies S.N., Rasband M.N., Olsson T., Moldenhauer A., Velhin S., Hohlfeld R., Meinl E., and Linington C. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 204 (2007) 2363-2372
36. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends. Immunol. 27 (2006) 17-23
37. Mendel I., Kerlero de Rosbo N., and Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
38. Mor F., Quintana F., Mimran A., and Cohen I.R. Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self beta-synuclein. J. Immunol. 170 (2003) 628-634
39. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198 (2003) 1951-1957
40. Pike G.B., de Stefano N., Narayanan S., Francis G.S., Antel J.P., and Arnold D.L. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR. Am. J. Neuroradiol. 20 (1999) 829-837
41. Pirko I., Lucchinetti C.F., Sriram S., and Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 68 (2007) 634-642
42. Quilty M.C., Gai W.P., Pountney D.L., West A.K., and Vickers J.C. Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma. Exp. Neurol. 182 (2003) 195-207
43. Sasaki A., and Nakazato Y. The identity of cells expressing MHC class II antigens in normal and pathological human brain. Neuropathol. Appl. Neurobiol. 18 (1992) 13-26
44. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., and Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203 (2006) 2673-2682
45. Sherriff F.E., Bridges L.R., Gentleman S.M., Sivaloganathan S., and Wilson S. Markers of axonal injury in post mortem human brain. Acta. Neuropathol. 88 (1994) 433-439
46. Silber E., Semra Y.K., Gregson N.A., and Sharief M.K. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58 (2002) 1372-1381
47. Tanji K., Mori F., Nakajo S., Imaizumi T., Yoshida H., Hirabayashi T., Yoshimoto M., Satoh K., Takahashi H., and Wakabayashi K. Expression of beta-synuclein in normal human astrocytes. Neuroreport 12 (2001) 2845-2848
48. Teunissen C.E., Dijkstra C., and Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet. Neurol. 4 (2005) 32-41
49. Thatte U. AN-1792 (Elan). Curr. Opin. Investig. Drugs 2 (2001) 663-667
50. Tsunoda I., Kuang L.Q., Libbey J.E., and Fujinami R.S. Axonal injury heralds virus-induced demyelination. Am. J. Pathol. 162 (2003) 1259-1269
51. Tuohy V.K. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem. Res. 19 (1994) 935-944
52. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., Kamoun M., and Rostami A. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170 (2003) 2153-2160